PCV5 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with No Treatment Under the Brazilian Private Health Care System Per ...
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1577
https://www.valueinhealthjournal.com/article/S1098-3015(11)03139-1/fulltext
Title :
PCV5 Cost-Effectiveness and Budget Impact Analysis of Rivaroxaban in the Prevention of Thromboembolic Events in Patients Performing Hip and Knee Arthroplasty in Comparison with No Treatment Under the Brazilian Private Health Care System Per ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)03139-1&doi=10.1016/j.jval.2011.08.1577
First page :
A545
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
1522